Provided by Oregon Attorney General’s Office
AstraZeneca will pay $1.4 million to Oregon under a multistate agreement that resolves unlawful marketing allegations
Attorney General John Kroger today announced a $68.5 million agreement with AstraZeneca Pharmaceuticals LP that settles allegations of illegal promotion of the antipsychotic drug Seroquel.
“Promoting drugs for illegal purposes undermines the public safety and trust in an already-broken health care system,” said Attorney General Kroger. “The resolution in this case should serve as a strong warning that we will not tolerate companies who attempt to mislead Oregon consumers.”
Oregon was among 37 states that participated in the three-year investigation into AstraZeneca’s alleged unlawful marketing scheme that promoted Seroquel for unapproved uses and specifically targeted vulnerable pediatric and geriatric populations. Specifically, AstraZeneca allegedly promoted the antipsychotic drug in nursing homes for treating Alzheimer’s disease and Dementia, as well as anxiety, depression, sleep disorders and post-traumatic stress disorder. Seroquel was not approved to treat those conditions at the time.